콘텐츠로 건너뛰기
Merck
  • Binding of plasma fibronectin to Candida albicans occurs through the cell binding domain.

Binding of plasma fibronectin to Candida albicans occurs through the cell binding domain.

Microbial pathogenesis (1994-12-01)
C Penn, S A Klotz
초록

Candida albicans yeast cells bind soluble human plasma fibronectin (Fn) through a glycoprotein receptor (adhesin) located on the cell surface. This work demonstrates that a 120 kDa proteolytic fragment of Fn encompassing the cell binding domain binds more avidly to the yeast cell adhesin than does the parent Fn molecule. The presence of binding of Fn fragments containing heparin- and gelatin-binding domains of Fn could not be detected. The binding of the 120 kDa fragment is inhibited by a monoclonal antibody to the cell binding domain containing the amino acid sequence, Arginine-Glycine-Aspartic acid (RGD) as well as by an RGD-containing approximately 23-mer Fn peptide, but not with heparin or GRGDSPL. The fact that the cell binding domain of soluble Fn binds more avidly than does the parent molecule may explain the difference in the interaction of soluble Fn and immobilized Fn with Candida. It is possible that, upon immobilization, Fn may expose domains of the molecule previously unexposed when the molecule is in the soluble state.

MATERIALS
제품 번호
브랜드
제품 설명

Sigma-Aldrich
Fibronectin Proteolytic Fragment from human plasma, lyophilized powder, 70 kDa